|
FAM175A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.67680014107452E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.73400000416757E-08 |
| Normal-vs-Stage2 |
2.69890000004214E-06 |
| Normal-vs-Stage3 |
1.23830000031688E-07 |
| Normal-vs-Stage4 |
9.49190000043565E-07 |
| Stage1-vs-Stage2 |
4.163000E-01 |
| Stage1-vs-Stage3 |
7.567200E-01 |
| Stage1-vs-Stage4 |
3.793600E-01 |
| Stage2-vs-Stage3 |
5.720400E-01 |
| Stage2-vs-Stage4 |
9.750000E-01 |
| Stage3-vs-Stage4 |
5.314000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.75629996393923E-09 |
| Normal-vs-AfricanAmerican |
1.859110E-03 |
| Normal-vs-Asian |
5.75210000000048E-05 |
| Caucasian-vs-AfricanAmerican |
7.670600E-01 |
| Caucasian-vs-Asian |
8.676800E-01 |
| AfricanAmerican-vs-Asian |
8.746000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60659996417678E-09 |
| Normal-vs-Female |
1.07440000229886E-08 |
| Male-vs-Female |
1.876840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.69000000005415E-06 |
| Normal-vs-Age(41-60Yrs) |
1.202000055045E-09 |
| Normal-vs-Age(61-80Yrs) |
1.5132999997558E-07 |
| Normal-vs-Age(81-100Yrs) |
1.673920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.412000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.406400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.163000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.895400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.891400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.935800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.930800E-01 |
| Classical-VS-Follicular |
1.020310E-03 |
| Classical-VS-Other |
9.247800E-01 |
| Classical-VS-Normal |
9.77840000082608E-08 |
| Tall-VS-Follicular |
5.199500E-02 |
| Tall-VS-Other |
9.288400E-01 |
| Tall-VS-Normal |
2.818800E-04 |
| Follicular-VS-Other |
3.885000E-01 |
| Follicular-VS-Normal |
7.61740004406875E-10 |
| Other-VS-Normal |
6.549700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.60389981482967E-10 |
| Normal-vs-N1 |
2.04739999953851E-07 |
| N0-vs-N1 |
4.396400E-01 |
|
|
